April 22nd, 2016|
Cory Watson Attorneys is pleased to announce that firm Co-Founder and Managing Shareholder Ernest Cory has been named to Who’s Who in Birmingham Law for 2016. Each year, the Birmingham Business Journal publishes the annual Who’s Who in Law special section – a feature that highlights the top leaders in the Magic City’s legal world.
Cory has practiced law for more than thirty years and has devoted his practice almost exclusively to mass torts, class actions and complex litigation involving defective medical devices, drugs, and environmental toxins. He is recognized nationally for his role in landmark pharmaceutical and defective medical device litigation including silicone breast implants and diet drug litigation.
Cory Watson has participated in litigation involving more than fifty different medical devices and drugs including Abilify, Viagra, Chantix, Transvaginal Mesh, GranuFlo, Stryker hip implants, DePuy, Vioxx, Baycol, Prempro, Medtronic, Guidant, Ortho-Evra, Fosamax, Mirena, Yaz, and others.
Cory is AV Rated by Martindale Hubbell and was named to the American Trial Lawyers Association Top 100 Lawyers. He is a charter member of Pioneers of Justice Society of the Alabama Civil Justice Foundation and serves on the Board of Directors and as Development Committee Chair of the Birmingham Bar Volunteer Lawyers Program. He serves on the Advisory Board of Cumberland School of Law. He was elected to Super Lawyers and Best Lawyers in America and was elected one of the Top 100 Attorneys in Birmingham in a peer review survey. Mr. Cory received his J.D. from Cumberland School of Law at Samford University in Birmingham, Alabama and is a graduate of the University of Alabama. Mr. Cory and his wife, Vivian, have five children.